Literature DB >> 2419688

Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers.

J P Bussien, J Biollaz, B Waeber, J Nussberger, G A Turini, H R Brunner, F Brunner-Ferber, H J Gomez, E S Otterbein.   

Abstract

Synthetic atrial natriuretic peptide, containing 26 amino acids in the rat sequence, L-364, 343 (Ileu-ANP), was infused intravenously at increasing rates (1-40 micrograms/min) into four normal volunteers. Mean intraarterial blood pressure decreased and heart rate increased in cumulative-dose-dependent fashion. Skin blood flow as measured with a laser Doppler device rose already with a cumulative dose of 55 micrograms Ileu-ANP and further rises were directly related to dose. The only side effects observed were those accompanying symptomatic hypotension at higher doses. These findings provide strong evidence that Ileu-ANP acts as a vasodilator in normal volunteers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419688     DOI: 10.1097/00005344-198601000-00031

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

Review 1.  Atrial natriuretic peptides: clues to their physiological and clinical importance.

Authors:  D R Singer
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

Review 2.  Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.

Authors:  B J Freund; C E Wade; J R Claybaugh
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 3.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

4.  Effects of intradermal injection of atrial natriuretic peptide.

Authors:  A M Sharara; M A Higham; A Spanevello; P W Ind
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

5.  Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension.

Authors:  P Larochelle; J R Cusson; J Gutkowska; E L Schiffrin; P Hamet; O Kuchel; J Genest; M Cantin
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

6.  The effect of atrial natriuretic peptide on human isolated resistance arteries.

Authors:  A D Hughes; H Nielsen; P S Sever
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

7.  Vascular responses to local atrial natriuretic peptide infusion in man.

Authors:  D J Webb; N Benjamin; M J Allen; J Brown; M O'Flynn; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

8.  Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow.

Authors:  J Biollaz; B Waeber; J Nussberger; M Porchet; F Brunner-Ferber; E S Otterbein; H J Gomez; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 9.  Neurohumoral Control of Sinoatrial Node Activity and Heart Rate: Insight From Experimental Models and Findings From Humans.

Authors:  Eilidh A MacDonald; Robert A Rose; T Alexander Quinn
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.